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Work early in the last century emphasized the stereotyped activity of spinal circuits
based on studies of reflexes. However, the last several decades have focused on the
plasticity of these spinal circuits. These considerations began with studies of the effects of
monoamines on descending and reflex circuits. In recent years new classes of compounds
called growth factors that are found in peripheral nerves and the spinal cord have been
shown to affect circuit behavior in the spinal cord. In this review we will focus on the
effects of neurotrophins, particularly nerve growth factor (NGF), brain derived neurotrophic
factor (BDNF) and neurotrophin-3 (NT-3), on spinal circuits. We also discuss evidence
that these molecules can modify functions including nociceptive behavior, motor reflexes
and stepping behavior. Since these substances and their receptors are normally present
in the spinal cord, they could potentially be useful in improving function in disease
states and after injury. Here we review recent findings relevant to these translational
issues.
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INTRODUCTION
Classical studies of spinal cord function have centered on well-
defined neural pathways that were considered to mediate stereo-
typed automatic functions such as stretch and flexion reflexes,
and to distribute input from sensory fibers and from descending
fibers to their appropriate targets. In the past several decades
it has become apparent that these projections are modifiable
and that this plays an important role in the physiology and
pathology of functions mediated by the spinal cord. Thus a
complete understanding the nature of spinal function as well
as spinal dysfunction requires knowledge of these processes. In
addition, such plasticity can serve potentially as a basis for revers-
ing pathological changes after injury or disease. Initial studies
of this type centered on the effects of monoamines on spinal
circuits because of the well-known projections of serotonergic
and noradrenergic projections to the spinal cord from the raphe
and locus coeruleus, respectively (Jankowska et al., 2000). More
recently, a different class of molecule has been shown capable
of altering spinal circuit function. These are the neurotrophins,
the most studied of which are nerve growth factor (NGF),
brain derived neurotrophic factor (BDNF), and neurotrophin-
3 (NT-3). These molecules interact with neurons that express
the appropriate tropomyosin related kinase (trk) receptor- trkA
(NGF), trkB (BDNF), and trkC (NT-3) as well as the p75 receptor
common to all trk- expressing neurons. The receptor biology and
intracellular signaling associated with trk receptors is reviewed
elsewhere (Chao and Hempstead, 1995; Huang and Reichardt,
2001).
NEUROTROPHIN EFFECTS ON SENSORY NEURONS AND
THEIR SPINAL PROJECTIONS
NGF
NGF was the first neurotrophin to be well characterized after
discovery of its ability to promote the growth of neurites when
applied to explanted dorsal root ganglia (reviewed in Cowan,
2001). Later, it was identified as a survival factor during the
period of programmed cell death for small sensory neurons
expressing the trkA receptor (reviewed in Mendell, 1995; Mendell
et al., 1999b; Huang and Reichardt, 2001). In the immediate
postnatal period, NGF continues to act as a survival factor, and
subjecting the animal to an anti NGF antibody leads to failure of
high threshold mechanoreceptors to survive (Lewin et al., 1992).
Beginning about 2 days after birth, withdrawing NGF has little
effect on nociceptor survival. However, during this same postnatal
period, these cells begin to show sensitization of the response to
noxious heat or capsaicin after application of NGF (Zhu et al.,
2004). This switch, occurring in the immediate postnatal period,
is associated with upregulation of ERK1/2 and PI3K/P110 in
dorsal root ganglion (DRG) cells, and does not appear to be due to
changes in expression of trkA or TRPV1 (Zhu and Oxford, 2011).
The sensitization elicited by NGF in adult nociceptive neurons
in the DRG results from an increase in the current produced by
TRPV1 receptor activation (Shu and Mendell, 1999a,b; Galoyan
et al., 2003). This increase is not due to enhanced sensitivity of
the TRPV1 receptors, but rather from recruitment of additional
TRPV1 receptors from the interior of the cell (Zhang et al.,
2005; Stein et al., 2006). The ability of NGF to sensitize the
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response of nociceptors to noxious heat stimuli has important
behavioral significance, namely that exposure of adult rats to
systemic NGF results in robust mechanical and thermal hyperal-
gesia. Thermal hyperalgesia has a strong peripheral component
while mechanical hyperalgesia induced by exposure to NGF is
mediated largely centrally (Lewin et al., 1994). The central effects
elicited from peripheral exposure to NGF are mediated by another
neurotrophin, BDNF, whose expression in the DRG is enhanced
several hours after administration of NGF (reviewed in Pezet and
McMahon, 2006). The synaptic action of BDNF is discussed in
more detail below.
NT-3
NT-3 plays a role similar to NGF in the survival of sensory
afferents, but in this case it is muscle spindle (group Ia) afferent
fibers expressing trkC (reviewed in Huang and Reichardt, 2001).
NT-3 also promotes the elaboration of their terminal projections
to motor neurons during late stages of development (Chen et al.,
2003), and in addition potentiates the strength of the group Ia
synaptic projection to motor neurons. In intact afferents this has
been studied by delivering the NT-3 systemically or intramus-
cularly (Arvanian et al., 2003; Petruska et al., 2010) and it is
difficult to determine the precise mode of action. For peripherally
axotomized afferent fibers the NT-3 was delivered via a cuff on the
cut nerve (Mendell et al., 1999). Because the effects were limited to
the treated nerve, it seems likely that this was due to a direct effect
of the NT-3 on the terminals of the fibers that were exposed to the
NT-3, but possible mechanisms such as sprouting or facilitation
of glutamate release could not be distinguished.
The monosynaptic projections from spindle afferent fibers to
motor neurons also exhibit potentiation acutely when exposed
to NT-3 in the isolated spinal cord (Arvanov et al., 2000). The
acute effect is developmentally regulated because the postsynaptic
(motor neuron) NMDA receptors required for the action of NT-
3 become inactive about 10–14 days after birth due to Mg block
(Arvanian and Mendell, 2001a; Arvanian et al., 2004). NT-3 also
enhances the mechanical sensitivity of the neuroma of spindle
afferents that have been axotomized and capped with a Gore-Tex
sleeve (Munson et al., 1999).
BDNF
The effect of the trkB agonist BDNF on sensory neurons is
more complex. Although BDNF also serves as a survival fac-
tor for sensory neurons during the period of programmed cell
death, the correspondence to a particular phenotype as has been
observed with NGF (nociceptors) and NT-3 (proprioceptors)
is not clearcut. Furthermore, another neurotrophin, NT-4, also
binds with the trkB receptor and can substitute for BDNF in
some, but not in all cases, to assure the survival of sensory neuron
populations (e.g., Erickson et al., 1996). BDNF, like NGF and NT-
3, is known to regulate the sensitivity of low threshold sensory
receptors, in this case the slowly adapting Type I mechanoreceptor
(Carroll et al., 1998); NT-4 regulates the sensitivity of a different
low threshold mechanoreceptor, the D- Hair (Hilaire et al., 2012).
Thermal nociceptors are also reported to be sensitized by NT4
(Rueff and Mendell, 1996) and by BDNF (Shu et al., 1999; Shu
and Mendell, 1999b).
An additional property of BDNF is that its expression in
nociceptor somata is upregulated by exposure to NGF in the
periphery as part of the response to peripheral inflammation
(Pezet and McMahon, 2006). Enhanced expression of BDNF in
the DRG results in increased levels of BDNF in the superficial
dorsal horn (Lever et al., 2001). This is known to rapidly enhance
the synaptic action of nociceptive afferents on cells of lamina II
via a mechanism involving NMDA receptors (Garraway et al.,
2003). It is interesting that NMDA receptors in these cells are not
subject to Mg block in the adult unlike those in motor neurons
(see above), presumably because their subunit composition differs
(Arvanian et al., 2004).
BDNF also acutely strengthens the monosynaptic reflex path-
way in the isolated spinal cord of neonates. However, this reverses
into long lasting inhibition of transmission several minutes after
BDNF exposure (Arvanian and Mendell, 2001b). The inhibitory
effect is thought to be due to a presynaptic effect of BDNF in
contrast to the potentiation, which has a postsynaptic mechanism,
as is the case for NT-3 (reviewed in Mendell and Arvanian, 2002).
In agreement with these long lasting postnatal changes, exposure
of the prenatal rat to BDNF by i.p. injection of the mother reduces
the monosynaptic EPSP measured postnatally, whereas prenatal
exposure to NT-3 increases it (Seebach et al., 1999).
SUMMARY
In summary, there are several common features linking the
effects of the different neurotrophins on sensory neurons. All
sensory neurons express trk receptors whose identity determines
which neurotrophin will influence their function. Neurotrophins
all serve as survival factors during the period of programmed
cell death. They all affect the response of receptors to nat-
ural stimulation, and finally they all are able to modify the
synaptic effects of the affected sensory neurons. In the latter
case the mechanisms are quite different. NGF elicits its effect
by upregulating another neurotrophin, BDNF, which elicits its
effect in the spinal cord by acting on NMDA receptors in cells
of the superficial dorsal horn. The effect of peripherally deliv-
ered NT-3 is not established, but probably involves a presy-
naptic change in the affected fibers. However, studies of the
acute action of NT-3 have also revealed the possibility of a
postsynaptic NMDA receptor- mediated change as discussed for
BDNF.
NEUROTROPHIN EFFECTS ON CIRCUITS IN THE INJURED
SPINAL CORD
Since spinal neurons differ in their relationship with the inputs
and outputs, we evaluate the spinal effects of neurotrophins by
investigating their action on functional circuits rather than on
individual neurons or neuron classes. In some cases the circuit
is sensory and is driven by specific sensory receptors. An example
is a circuit that processes nociceptive input. Another circuit is the
pattern generator which delivers an output causing stepping. A
third circuit is the sensorimotor circuit responsible for the stretch
reflex that converts muscle stretch into muscle contraction.
Although NGF has played a prominent role in investigating
the role of neurotrophins on sensory fibers, most studies of
neurotrophin action on spinal circuit function have been limited
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to BDNF and NT-3. TrkB and trkC receptors are expressed at a
higher level than trkA receptors within the spinal cord (Liebl et al.,
2001) thus raising the expectation that BDNF and NT-3 would be
more effective in affecting spinal circuit function. Here we discuss
the effect of BDNF and NT-3 on three circuits based on their
effects on three behaviors: stepping, nociception, and the stretch
reflex.
STEPPING
Application of neurotrophins to the injured spinal cord at the time
of thoracic transection promotes stepping behavior in both cats
(Boyce et al., 2007) and rats (Jakeman et al., 1998; Blits et al.,
2003; Boyce et al., 2012b). Boyce et al. (2012b) reported that
rats with intraspinal administration of AAV viruses engineered
to express BDNF to a site just caudal to the T10 transection
site could carry out plantar stepping with their hind limbs on a
treadmill. Remarkably, these rats could also carry out overground
stepping across a stationary surface requiring the provision of
balance support only (i.e., without treadmill assistance). Training
was not required for BDNF to exert any of these effects which
developed over the first 2–4 weeks after transection and exposure
to the AAV/BDNF.
Further evidence for BDNF- activation of neurons involved
in stepping was a finding of elevated expression of c-Fos in
cells of the intermediate zone in the upper lumbar spinal cord
of these rats. Relatively little increase of c-Fos expression was
observed in the ventral horn. There was a rostrocaudal gradi-
ent of c-Fos expression after administration at T10 such that it
was greater at L2 than at L4/L5. Expression of c-Fos was not
associated with enhanced neural activity per se because the rats
had been anesthetized for an electrophysiological experiment
for several hours prior to sacrifice. It is more likely that its
expression was a direct effect of BDNF on these cells, as has
been observed previously in dissociated embryonic hippocampal
cells (Paul et al., 2001). However, c-Fos expression provided
an indication that BDNF influenced L2 interneurons. Since L2
intermediate zone interneurons are likely crucial participants
in the central pattern generator (CPG; reviewed in Goulding,
2009), it seems likely that this increase in c-Fos expression reflects
the action of interneurons whose activity is responsible for the
stepping behavior elicited by BDNF, i.e., c-Fos is a biomarker
for stepping, at least under these conditions. The mechanism
of BDNF action on this circuits remains to be determined,
i.e., whether it is a generalized increase in excitability, activa-
tion of a specific subgroup of cells in this circuit or of cells
driving it.
These findings in the transected cord suggest that the exoge-
nous BDNF acts on trkB receptors to elevate activity in neurons
of the locomotor circuit. This effect may be diminished to some
extent by the presence of truncated trkB receptors whose expres-
sion is elevated in the spinal cord after contusion (Liebl et al.,
2001). These authors suggest that the truncated receptors with
a non-signaling intracellular component act to sequester BDNF
thereby reducing its effect. More recent data have shown that
deleting the truncated form of trkB receptor improves locomotor
recovery after spinal contusion injury even without provision of
exogenous BDNF (Wu et al., 2013).
NOCICEPTION
Elevation of BDNF levels also results in increased sensitivity to
a noxious heat stimulation as would be expected by sensitizing
or activating cells in the superficial dorsal horn (Garraway et al.,
2003). Cells in this region express elevated c-Fos indicating a
response to BDNF as reported for cells in the intermediate zone.
These findings raise the question as to whether activating noci-
ceptive circuits is a requirement for BDNF to elicit overground
stepping, i.e., stepping is a component of the response to noxious
stimulation. There are no direct studies of this issue, but a recent
report (Garraway et al., 2011) indicates that the relationship
between BDNF, stepping and nociception is at the very least quite
complex.
In experiments comparing the effects of NT-3 and BDNF
on stepping under comparable conditions, NT-3 promoted only
treadmill-assisted stepping with the further requirement, not
needed for BDNF, for perineal stimulation accomplished by
squeezing the base of the tail (Boyce et al., 2012b). Furthermore,
NT-3 did not sensitize the response to nociceptive stimulation.
Consistent with both of these findings was the finding of no
increase in c-Fos expression in the spinal cord, either in the
intermediate zone or in the superficial dorsal horn. It is not
known whether this is due to differences in signaling elicited by
trkB and trkC activation or whether there are few trkC receptors
on cells eliciting the nociceptive and stepping behavior.
Another model demonstrating the pro-nociceptive role of
BDNF comes from the response to peripheral nerve injury. Under
these conditions BDNF has been shown to be released from
microglia in the superficial dorsal horn that have been sensitized
by the purinergic transmitter ATP released from the central ter-
minals of damaged nociceptors (Tsuda et al., 2003). The activated
microglia release BDNF that in turn reduces the level of the Cl−
transporter KCC2 in neurons of the dorsal horn. This diminishes
the inhibitory action of GABA, and in extreme cases converts it
to an excitatory action (Coull et al., 2005). Thus neurotrophins
can be released from non-neuronal cells, a mechanism that has
been known for many years in the periphery where Schwann Cells
associated with damaged peripheral fibers release neurotrophins
whose identity is associated with the fiber type (reviewed in
Lehmann and Höke, 2010).
MOTONEURONS AND THE MONOSYNAPTIC REFLEX
BDNF causes increased excitability of motor neurons in the
injured cord as evidenced by a reduced rheobase (Gonzalez and
Collins, 1997; Boyce et al., 2012b) despite the lack of significantly
altered c-Fos expression in the ventral horn. Of interest in this
context is the finding that BDNF delivered in a single dose 24 h
after transection has been reported to increase expression of the
KCC2 chloride transporter in motor neurons of transected prepa-
rations (Boulenguez et al., 2010). This would oppose any intrin-
sic increase in excitability of motor neurons by enhancing the
magnitude of inhibition due to establishment of a more negative
chloride equilibrium potential. However, chronically transected
preparations treated with continuous BDNF administration via
engineered AAV viruses exhibit reduction in expression of the
KCC2 transporter (see also preliminary data in Boyce et al.,
2012a; Ziemlinska et al., 2014). This is an important area that
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requires further study, particularly in view of the recent finding
indicating elevated levels of GABA and GABA- synthetic enzymes
caudal to spinal transection (Ziemlinska et al., 2014). A combined
reduction in motor neuron rheobase and a reduction in synaptic
inhibition of motor neurons would be expected to promote
spasticity as has been reported after BDNF administration (Boyce
et al., 2012b; Fouad et al., 2013; Ziemlinska et al., 2014).
The effect of NT-3 on motor neuron excitability is opposite
to that of BDNF, i.e., a reduced excitability (increased rheobase;
see also Petruska et al., 2010; Boyce et al., 2012b). However, the
decrease in intrinsic motor neuron excitability after NT-3 treat-
ment is opposed by an increase in monosynaptic EPSP amplitude
and a decrease in the after hyperpolarization (AHP) following the
spike, each of which should enhance the strength of excitatory
response directly (elevated EPSP) or indirectly (diminished AHP).
Unlike NT-3, BDNF has no effect on the strength of synaptic
projections to motor neurons in these preparations although as
discussed above it enhances motor neuron excitability and can
reduce synaptic inhibition via reduced KCC2 at least under some
conditions.
SELECTIVITY OF NEUROTROPHIN EXPRESSION
Figure 1 shows that summing the separate effects of BDNF and
NT-3 on the electrophysiology of motor neurons and their spindle
synaptic input gives a result that is in qualitative agreement with
the effects of motor training in spinal transected rats (Petruska
et al., 2007) where the levels of BDNF and NT-3 are both increased
(Ying et al., 2005; Côté et al., 2011; de Leon et al., 2011). This is
consistent with the idea that training exerts its effects via changes
in neurotrophin expression (Gómez-Pinilla et al., 2001). The
increase in both BDNF and NT-3 after motor training differs
from what is observed after increase in activity limited to pro-
prioceptive pathways where NT-3 levels are increased but BDNF
levels are not (Gajewska-Wozniak et al., 2013). This indicates that
locomotor training involves more than altering the stretch reflex
pathway despite its enhancement after step training (Petruska
et al., 2007), and the beneficial effects of increasing it by operant
conditioning (Thompson et al., 2013). These beneficial effects of
stretch reflex enhancement may be due to improved weight sup-
port which facilitates stepping elicited by independent activation
of the CPG.
The pathway- selective increase in neurotrophin levels is also
observed for BDNF in that inflammatory pain results in upreg-
ulation of BDNF in trkA- expressing nociceptive neurons in the
FIGURE 1 | Comparison of effects of NT-3, BDNF and step training on
electrophysiological properties of motor neurons. Note that training
gives results that are qualitatively equivalent to the sum of the separate
effects of NT-3 (data row 1) and BDNF (data row 2). The data are derived
from Petruska et al. (2007), Petruska et al. (2010) and Boyce et al. (2012b).
DRG (Pezet and McMahon, 2006) with subsequent release into
the superficial dorsal horn of the spinal cord (Lever et al., 2001).
Thus activity- driven elevation in neurotrophin levels is circuit-
dependent and acts to potentiate the central effect of the activated
fibers.
NEUROTROPHINS AND REPAIR OF SPINAL CIRCUITS
Investigating a possible role for neurotrophins in the treatment
of spinal injuries was prompted by earlier results in the devel-
oping spinal cord suggesting that these agents could encourage
growth of axons. Thus there are many studies in which bridges
of Schwann cells, olfactory ensheathing glia or other substrates
were treated with neurotrophins to enhance elongation of cut
axons (reviewed in Boyce et al., 2014; Boyce and Mendell, 2014).
Additional studies in which neurotrophins were applied either to
the severed proximal end of descending fibers in the vicinity of a
spinal injury or to the cell body in the brainstem or cerebral cortex
revealed their ability to promote the growth of axons descending
from more rostral centers with some specificity. For example,
BDNF stimulates growth of vestibulospinal fibers whereas NT-
3 enhances corticospinal fiber growth although the specificity of
action may not be absolute (see reviews in Boyce et al., 2014;
Boyce and Mendell, 2014). As expected from the specificity of
neurotrophin receptor expression on sensory axons (see Section
Neurotrophin Effects on Sensory Neurons and their Spinal Pro-
jections), NGF enhances the ability of nociceptive afferent fibers
to grow past a crush injury in the dorsal root and terminate in
the appropriate area of the superficial dorsal horn whereas after a
similar injury NT-3 stimulates growth of proprioceptors into the
ventral horn (see review by Smith et al., 2012). At present, there
is little information concerning direct effects of neurotrophins on
the activity of spinal neurons recorded in vivo, in part because any
observed activity changes might be an indirect action, e.g., due to
activation of sensory fibers. Nonetheless, direct effects on spinal
neuron activity would be expected because there are reports of
trk receptors on these neurons (Liebl et al., 2001). Furthermore,
some of the synaptic effects of exogenously applied neurotrophins
in the isolated spinal cord have been attributed to trk receptors on
the postsynaptic spinal neurons (Arvanov et al., 2000; Garraway
et al., 2003).
Long term intrathecal treatment with neurotrophins can also
promote the development of novel functional pathways in the
spinal cord, specifically the formation of functional detours
around zones of injury both in neonatal (Arvanian et al., 2006)
and adult rats (García-Alías et al., 2011; Schnell et al., 2011). In
adults the neurotrophin works best if supplemented with agents
that overcome the inhibitory effect of the tissue on axonal growth,
e.g., anti Nogo or chondroitinase (reviewed in Fawcett et al.,
2012), and provision of NMDA subunit NR2D to bring these
receptors back to their juvenile state (Arvanian et al., 2004). In
these experiments, neurotrophins were introduced intrathecally
using either engineered fibroblasts or viruses. The fibroblasts
or the cells infected by the AAV viral vectors released the neu-
rotrophin which interacted with the trk or p75- (reviewed in
Nicol and Vasko, 2007) expressing cells resident in the CNS.
Some success has also been reported in altering connections to
motoneurons retrogradely by administering viruses expressing a
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neurotrophin to muscle (Fortun et al., 2009; Petruska et al., 2010).
The peripheral administration approach might have important
translational advantages.
Many investigators are now making efforts to repair the injured
spinal cord using cell transplants including stem cells. In eval-
uating the results of these procedures it is important to keep
in mind that these cells constitutively release neurotrophins (Lu
et al., 2003), which could affect the function of spinal neurons
and circuits in addition potentially promoting axonal elongation.
MALADAPTIVE EFFECTS OF NEUROTROPHINS
Although neurotrophins have numerous potentially useful effects
on the injured spinal cord, there are many potential drawbacks.
Improving stepping might be negated by increased pain or spas-
ticity both of which have been reported (Boyce et al., 2012b;
Fouad et al., 2013; see review by Weishaupt et al., 2012). This
may be the result of the multiplicity of actions of neurotrophins,
particularly BDNF which elicits activity- based plasticity as well
as activating microglia leading to pain. One might question why
the same molecule has developed adaptive and maladaptive roles.
In evaluating this issue it is important to remember that the
different mechanisms are being studied in isolation in prepara-
tions that are often so severely injured (e.g., peripheral nerve
injury, spinal cord injury) that any evolutionary significance is
doubtful.
It remains to be seen whether adjusting the dosage of BDNF
will help to balance the positive and negative effects of this
treatment so that it might be used translationally. Alternatively,
an approach allowing BDNF release to be turned on and off
using a regulatable viral system might be possible. Finally, a
discrete infusion of BDNF into motor pools via an indwelling
catheter might improve the balance between the positive and
negative effects of this agent. In support of this approach,
Mantilla et al. (2013) recently demonstrated enhanced respira-
tion leading to increased survival of cervically hemisected rats
after chronic infusion of BDNF into the phrenic motor neuron
pool.
CONCLUSION
It appears, then, that neurotrophins, particularly BDNF, can have
numerous actions that affect circuit function in the spinal cord
(Figure 2). It follows that any attempt to use neurotrophins to
promote repair will require targeting them to specific classes
of cells, e.g., the CPG but not the nociceptive circuits in the
superficial dorsal horn. So far this has not been possible using
engineered cells, viral vectors or osmotic minipumps. Alterna-
tively, it may be possible to devise cell based treatments which
are easily turned off to control side effects. At present, what is
clear is that neurotrophins are powerful molecules that could
be very useful in repairing the injured cord. It will be necessary
to recognize that they have significant effects on functional
properties of cells and circuits as well as on axon elongation
and to take this into account when devising protocols for
their use.
FIGURE 2 | Schematic diagram of circuitry affected by neurotrophins
after application via engineered AAV viruses to the transected spinal
cord. Behavioral, electrophysiological and immunocytochemical data indicate
that such injections affect the CPG in upper lumbar segments, nociceptive
processing in the dorsal horn and the stretch reflex pathway. Further
discussion of these effects in the text.
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